Chondromyxoid fibroma of the skull base☆☆☆★

1998 ◽  
Vol 118 (3) ◽  
pp. 415-418 ◽  
Author(s):  
J PATINOCORDOBA ◽  
J TURNER ◽  
S MCCARTHY ◽  
P FAGAN
2021 ◽  
Author(s):  
Christopher Weeks ◽  
Ya Xu ◽  
Ali Jalali ◽  
Kelly Gallagher

1997 ◽  
Vol 21 (5) ◽  
pp. 577-582 ◽  
Author(s):  
Suzanne B. Keel ◽  
Atul K. Bhan ◽  
Norbert J. Liebsch ◽  
Andrew E. Rosenberg

2005 ◽  
Vol 44 (6) ◽  
pp. 545-553 ◽  
Author(s):  
Loïc Feuvret ◽  
Georges Noël ◽  
Valentin Calugaru ◽  
Philippe Terrier ◽  
Jean-Louis Habrand

Skull Base ◽  
2009 ◽  
Vol 20 (02) ◽  
pp. 101-104 ◽  
Author(s):  
Matthew Crocker ◽  
Robert Corns ◽  
Istvan Bodi ◽  
Antoine Zrinzo ◽  
Michael Gleeson ◽  
...  

2017 ◽  
Vol 78 (06) ◽  
pp. 576-581 ◽  
Author(s):  
Giancarlo D'Andrea ◽  
Guido Trasimeni ◽  
Venceslao Wierzbicki ◽  
Veronica Picotti ◽  
Alessandra Serraino ◽  
...  

Chondromyxoid fibroma (CMF) is an extremely rare lesion of the skull base. This histologic type typically predilects metaphysis of the long bones. It is locally invasive/infiltrative, and this tendency is more concerning in the skull base, where a radical resection is often technically impossible because of the presence of vital neurovascular structures. We present a case of a 19-year-old woman who presented with a sudden onset of right facial weakness, progressively worsening to a severe disfiguring motor weakness. Gadolinium-enhanced brain magnetic resonance imaging showed an osteolytic lesion located in the right mastoid involving the stylomastoid foramen and the right seventh cranial nerve. A partial mastoidectomy was performed, with an excellent rate of tumor resection and complete local control of the disease at follow-up. The analysis of current literature indicates that a radiologic diagnosis is rarely strictly convincing of CMF. Histologic diagnosis is often difficult due to the lack of a specific immunohistochemical pattern of chondrosarcoma. Surgery is currently recognized as the mainstay to manage this lesion, although a trend toward adjuvant radiation therapy (RT) currently is seen. Although a tendency of local recurrence is well recognized in the literature, the very slow and indolent behavior of this lesion plus the trend to enhance local control of the disease with high-dose RT pushed us to a reappraise the role of radical skull base surgeries burdened by the risks of major complications, cosmetic deformities, and additional neurologic deficits.


1999 ◽  
Vol 113 (4) ◽  
pp. 380-385 ◽  
Author(s):  
T. W. H. Shek ◽  
W. C. G. Peh ◽  
G. Leung

AbstractChondromyxoid fibroma of the skull base is extremely uncommon. Sometimes involvement of the nasal cavity may occur and the patients may present with nasal symptoms. The biological behaviour of this tumour has not been well studied, primarily because of the limited number of reported cases and the short duration of followup. We report a histologically confirmed case of chondromyxoid fibroma of the skull base that recurred repeatedly over a 10-year period after the initial operation. Histologically it showed identical morphology to the original tumour with no evidence of histological progression or dedifferentiation. Ultrastructurally, the spindle tumour cells in the fibromyxoid area showed dual chondroblastic and fibroblastic differentiation, suggesting that these spindle fibroblastic cells and the better differentiated chondroid cells were of the same cell type with different histological morphology.


1986 ◽  
Vol 19 (4) ◽  
pp. 797-804 ◽  
Author(s):  
Yosef P. Krespi ◽  
Toni M. Levine ◽  
Randy Oppenheimer

Sign in / Sign up

Export Citation Format

Share Document